EFFICACY OF THIONONTRITE-S FOR PREVENTION OF METABOLIC LIVER DISEASE IN CATTLE by Ye. V. Tyapkina, M. P. Semenenko, Ye. V.  Kuzminova, A. A.  Abramov

“…The study data of the efficacy of thionontrite-S-complex preparation in the prevention of metabolic liver disease of cattle are presented. Administration of the preparation to 6–7-month-old cows in dry period for two weeks at a dose of 0.3 g/kg of body weight corrects biochemical homeostasis and prevents the development of pathogenetic shifts during metabolic liver disease. …”
Get full text

The Function of T Follicular Helper Cells in the Autoimmune Liver Diseases by Lin Li, Panyang Xu, Qi Zhou, Jiancheng Xu

“…When dysregulated, TFH cells may represent an important mechanism that contributes to a heightened humoral response and autoantibody production in autoimmune liver diseases (AILDs). TFH cells participate in the immune response associated with AILDs by expressing surface receptors such as programmed cell death protein-1, C-X-C motif chemokine receptor 5, and inducible T cell costimulators, as well as cytokines such as interleukin-21. …”
Get full text

Peroxisome proliferator–activated receptor delta and liver diseases by Tomoo Yamazaki, Edward E. Cable, Bernd Schnabl

“…PPAR-delta not only regulates physiologic processes of lipid, glucose, and bile acid metabolism but also attenuates pathologic responses to alcohol metabolism, inflammation, fibrosis, and carcinogenesis, and is considered an important therapeutic target in liver diseases. Promising results have been reported in clinical trials for PPAR-delta agonists in liver disease, and the selective agonist seladelpar was recently conditionally approved in the United States as a new treatment option for primary biliary cholangitis. …”
Get full text

Biomarkers in Liver Disease: Emerging Methods and Potential Applications by Guruprasad P. Aithal, Neil Guha, Jonathan Fallowfield, Laurent Castera, Andrew P. Jackson

Get full text

Retinopathy in Metabolic Dysfunction-Associated Steatotic Liver Disease by Myrsini Orfanidou, Stergios A. Polyzos

Subjects: “…metabolic dysfunction-associated steatotic liver disease…”
Get full text

Alcohol-induced liver disease: primary and secondary prevention by S. V. Plyusnin, K. V. Ivashkin, A. N. Bobrov, S. A. Belyakin, I. V. Plyusnina

Get full text

Algorithm of management of patient with alcohol-induced liver disease by M. V. Mayevskaya, M. A. Morozova

Subjects: “…alcohol-induced liver disease…”
Get full text

Recent trends in studying of alcohol-induced liver disease by I. I. Komkova, M. S. Zharkova, M. V. Mayevskaya

Subjects: “…alcoholic liver disease…”
Get full text

NK Cell Subtypes as Regulators of Autoimmune Liver Disease by Guohui Jiao, Bangmao Wang

“…However, the precise regulatory mechanisms at work in autoimmune liver diseases remain to be identified. In this review, we focus on recent research with NK cells and their potential role in the development of autoimmune liver disease.…”
Get full text

Nonalcoholic Fatty Liver Disease: Its Mechanisms and Complications by Abdelfattah El Ouaamari, Kaori Minehira

Get full text

Treatment of HCV infection in patients with steatotic liver disease by Robert Flisiak, Dorota Zarębska-Michaluk, Krystyna Dobrowolska, Justyna Janocha-Litwin, Dorota Dybowska, Marek Sitko, Łukasz Socha, Beata Lorenc, Jakub Klapaczyński, Jakub Brodowski

Subjects: Get full text

The Role of Liver Biopsy in the Management of Patients with Liver Disease by Florence Wong

“…The role of liver biopsy in the diagnosis and management of liver disease is a controversial issue even among hepatologists. …”
Get full text

The CYP4/20-HETE/GPR75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease by James P. Hardwick, Byoung-Joon Song, Paul Rote, Charles Leahy, Yoon Kwang Lee, Alexandra Rudi Wolf, Danielle Diegisser, Victor Garcia

Subjects: Get full text

Principles of effective out-patient diagnostics of diffuse liver diseases by Komova A. G., M. V. Mayevskaya, V. T. Ivashkin

Subjects: “…diffuse liver diseases…”
Get full text

Propensity Score Matching Analysis for Alcohol‐Related Liver Disease by Fangfang Duan, Shanshan Song, Hang Zhai, Yazhi Wang, Jun Cheng, Song Yang

Subjects: “…alcohol‐related liver disease…”
Get full text

Current Views of Torque Teno Virus (TTV) in Liver Diseases by I. V. Maev, T. I. Karlovich, A. I. Burmistrov, I. A. Chekmazov, D. N. Andreev, V. I. Reshetnyak

Get full text

Application of glycyrrhizinic acid in treatment of patients with alcoholic liver disease by I. G. Nikitin, I. Ye. Baykova, V. M. Volynkina, L. M. Gogova, G. I. Storozhakov, M. P. Prushkovskaya

Subjects: “…alcohol-induced liver disease…”
Get full text

Options of dyslipidemia treatment at non-alcoholic fatty liver disease by M. V. Mayevskaya, M. A. Morozova

“…To consider different treatment options for dyslipidemia in non-alcoholic fatty liver disease (NAFLD). Summary. NAFLD occurs in 20-30% of adult population. …”
Get full text

Treatment response rate and life prognosis at autoimmune liver diseases by K. V. Ivashkin, Ye. N. Shirokova, V. T. Ivashkin

“…To carry out comparative analysis of modern studies, to characterize actual modes of treatment and to define prognosis and features of treatment response at various autoimmune liver diseases.Key points. Diagnostics and treatment are the most complex and insufficiently investigated aspects of autoimmune liver diseases. …”
Get full text

Nonalcoholic Fatty Liver Disease-Related Chronic Kidney Disease by Camelia Cojocariu, Ana-Maria Singeap, Irina Girleanu, Stefan Chiriac, Cristina M. Muzica, Catalin Victor Sfarti, Tudor Cuciureanu, Laura Huiban, Carol Stanciu, Anca Trifan

“…Advances in the treatment of chronic viral hepatitis in recent years have opened the way towards reducing mortality in patients with chronic liver disease. This goal has not yet been reached, as the burden of chronic liver disease remains a future major health problem as the incidence of the nonalcoholic fatty liver disease continues to rise. …”
Get full text